Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction.
Karabay CY, Kocabay G, Oduncu V, Kalayci A, Guler A, Karagöz A, Candan O, Basaran O, Zehir R, Izgi A, Esen AM, Kırma C.
Karabay CY, et al. Among authors: izgi a.
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):387-93. doi: 10.1002/ccd.24839. Epub 2013 Mar 2.
Catheter Cardiovasc Interv. 2013.
PMID: 23361975